Show simple item record

Does trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer?

dc.contributor.authorSarsenov, D.
dc.contributor.authorPilanci, K. N.
dc.contributor.authorAlco, G.
dc.contributor.authorOrdu, C.
dc.contributor.authorCelebi, F.
dc.contributor.authorOzmen, V.
dc.contributor.authorIlgun, S.
dc.contributor.authorAgacayak, F.
dc.contributor.authorIyigun, Z. Erdogan
dc.date.accessioned2021-03-03T09:21:03Z
dc.date.available2021-03-03T09:21:03Z
dc.identifier.citationPilanci K. N. , Alco G., Ordu C., Celebi F., Sarsenov D., Iyigun Z. E. , Agacayak F., Ilgun S., Ozmen V., "Does trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer?", BREAST, cilt.24, 2015
dc.identifier.issn0960-9776
dc.identifier.othervv_1032021
dc.identifier.otherav_1c94e01f-0e58-473e-a897-e42499a792c9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/24454
dc.identifier.urihttps://doi.org/10.1016/s0960-9776(15)70157-8
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectONKOLOJİ
dc.titleDoes trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer?
dc.typeMakale
dc.relation.journalBREAST
dc.contributor.departmentİstanbul Bilim Üniversitesi , ,
dc.identifier.volume24
dc.contributor.firstauthorID221359


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record